All Stories

  1. Cardiac troponin measurement at the point of care: educational recommendations on analytical and clinical aspects by the IFCC Committee on Clinical Applications of Cardiac Bio-Markers (IFCC C-CB)
  2. Caveat emptor – hidden pitfalls in defining the 99th percentile of cardiac troponin assays
  3. Biotin interference in cardiac troponin immunoassay – where the wild things are?
  4. Cardiac biomarkers by point-of-care testing – back to the future?
  5. Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain-the WESTCOR study: study design
  6. Too much of a good thing – the over requesting of cardiac troponin
  7. Troponin, delta change and the evolution of cardiac biomarkers – back to the future (again)
  8. Troponin measurement in patients with suspected acute coronary syndromes - walking beyond the wall.
  9. Heart Fatty Acid Binding Protein for the Diagnosis of Myocardial Ischemia and Infarction
  10. In Search of Normality for Cardiac Biomarkers in Cardiovascular Disease Detection
  11. Are Heart Failure Management Recommendations and Guidelines Followed in Laboratory Medicine in Europe and North America? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) Study
  12. The Dilemma of Finding a Young Patient with a Raised Cholesterol Concentration
  13. Measurement of Lipoproteins: Upping the Game in Characterizing the Lipid Phenotype
  14. How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE)
  15. High-sensitivity troponin measurements: challenges and opportunities for the laboratory and the clinician